School of Medicine
Showing 21-40 of 95 Results
-
David Scheinker
Clinical Professor, Pediatrics - Endocrinology
Clinical Professor, MedicineBioDavid Scheinker is the Executive Director of Systems Design and Collaborative Research at the Stanford Lucile Packard Children's Hospital. He is the Founder and Director of SURF Stanford Medicine, a group that brings together students and faculty from the university with physicians, nurses, and administrators from the hospitals. SURF has implemented and published dozens of projects demonstrating improvements to the quality and efficiency of care. His areas of focus include clinical care delivery, technical improvements to hospital operations, sensor-based and algorithm-enabled telemedicine, and the socioeconomic factors that shape healthcare cost and quality.
Before coming to Stanford, he was a Joint Research Fellow at The MIT Sloan School of Management and Massachusetts General Hospital. He received a PhD in theoretical math from The University of California San Diego under Jim Agler. He advises Carta Healthcare, a healthcare analytics company started by former students. -
Alan Schroeder
Clinical Professor, Pediatrics
BioDr. Schroeder is the associate chief for research in the division of pediatric hospital medicine at Lucile Packard Children’s Hospital Stanford, and a clinical professor in the division of hospital medicine and the division of critical care. His research interests focus on identifying areas where we can “safely do less” in healthcare, striving to ensure that children get the healthcare that they need while avoiding excessive tests and treatments that only cause harm. Dr. Schroeder is currently involved in multiple projects involving common conditions and interventions in pediatrics. He serves as the Stanford PI for PEDSNet and is an Associate Editor for the journal Hospital Pediatrics. At Stanford he co-leads the residency clinical research scholarly concentration and the faculty Clinical Research Peer Scholarship Community. Dr. Schroeder provides clinical care for children in the PICU and the pediatric ward.
-
Christopher Thomas Scott, PhD, MLA
Sr Research Scholar, Pediatrics - Center for Biomedical Ethics
Current Research and Scholarly InterestsMy research focuses on the political, legal, ethical and economic impacts of stem cell research. Topics include: embryonic and adult stem cell research and clinical trials, stem cell banking, human-animal chimeras; cell and gamete donation; international perspectives of bioethics; global economic impacts; national and state regulatory policy, stem cell entrepreneurship, intellectual property and offshore stem cell transplants.
-
Talal Seddik
Clinical Associate Professor, Pediatrics - Infectious Diseases
Current Research and Scholarly InterestsTalal Seddik is a member of the Collaborative Antiviral Study Group. He is the key site investigator at the Stanford site for the following multicenter studies:
1) Enterovirus Natural History Study
Neonatal Enterovirus and Human Parechovirus Viral Sepsis: Natural History and Predictors of Morbidity and Mortality
This study is actively enrolling subjects
2) Acute Flaccid Myelitis (AFM) Study
A Prospective Study of Acute Flaccid Myelitis (AFM) to Define Natural History, Risk Factors and Pathogenetic Mechanisms
This study is closed for enrollment.
3) Congenital CMV Follow up Study
A Retrospective Follow-Up Study of The Durability of Antiviral Therapy on Long-Term Hearing and Neurodevelopmental Outcomes Among Patients Treated for Congenital Cytomegalovirus
Infection as Infants or Toddlers
https://cpic.rarediseasesnetwork.org/research-study/8604 -
Jennifer Andrene Sequoia
Instructor, Pediatrics - Neonatology
BioJennifer Sequoia, MD, PhD is an Instructor in Neonatology at Stanford University. She completed her Neonatology Fellowship and Pediatrics Residency (Research Track) at Stanford. Prior to coming to Stanford she received her undergraduate and master's degrees from University of California, San Diego and her MD and PhD degrees from The University of Chicago. As faculty at Stanford, she is developing a research program to understand how endogenous cannabinoids impact preeclampsia and other perinatal diseases. She is broadly interested in how lipids mediate inflammatory programs and is working to develop new molecular tools to study lipids in their native environments.
-
Ami J. Shah
Clinical Professor, Pediatrics - Stem Cell Transplantation
BioDr. Shah joined Stanford University in 2015 as a Clinical Professor of Pediatrics in the Division of Hematology/ Oncology, Stem Cell Transplantation and Regenerative Medicine. Dr. Shah completed medical school at the University of North Carolina- Chapel Hill. She completed her training in Pediatrics and Pediatric Hematology/ Oncology at Childrens Hospital Los Angeles. Her areas of clinical expertise have been in stem cell transplantation for malignant and non-malignant disorders. She has been actively involved with the care and treatment of children with primary immune deficiencies and is the site PI for the Primary Immune Deficiencies Consortium (PIDTC). She has experience in numerous gene therapy trials for primary immune deficiencies, hemoglobinopathies and other genetic diseases. She has a specific interest in the long term outcomes following HSCT, in specific the neurocognitive function post HSCT. She has been an active participant in American Society of Transplantation and Cellular Therapy (ASTCT), Children's Oncology Group (COG) and American Society of Hematology (ASH).
She has been actively involved with mentorship and graduate medical education, and currently serves as the Program Director for the Pediatric Hematology/ Oncology Fellowship and the Pediatric Stem Cell Fellowship. She also serves on the Pediatric Mentoring Group. -
Manish I. Shah, MD, MS
Professor of Emergency Medicine (Pediatrics) and, by courtesy, of Pediatrics (Hospital Medicine)
BioI have dedicated my career to improving pediatric prehospital care on local, statewide, national, and international levels through research, education, and advocacy. My primary research interest focuses on integration of pediatric evidence into emergency medical services (EMS) systems. I serve on the Executive Committee of the Pediatric Emergency Care Applied Research Network (PECARN) as the nodal Principal Investigator (PI) for the Charlotte, Houston, and Milwaukee Prehospital (CHaMP) research node. In addition, I am the PI for the Pediatric Dose Optimization for Seizures in EMS (PediDOSE) clinical trial and co-investigator for the Pediatric Prehospital Airway Resuscitation Trial (Pedi-PART). As an educational researcher, I have obtained several grants to produce an online EMS educational resource for physicians, create the Pediatric Simulation Training of Emergency Prehospital Providers (PediSTEPPs) program, and study the implementation of an EMS training curriculum for the Botswana Ministry of Health. As an EMS advocate, I led the Prehospital and State Partnership domains for the national EMS for Children (EMSC) Innovation and Improvement Center (EIIC), served as an appointed member of the National Emergency Medical Services Advisory Council (NEMSAC), chaired the EMS subcommittee for the American Academy of Pediatrics Section of Emergency Medicine, and directed the EMSC State Partnership in Texas. I have published policy on pediatric readiness in EMS systems and co-chaired the workgroup that created the first-ever national assessment of pediatric readiness of EMS systems for the National Prehospital Pediatric Readiness Project (PPRP).
-
Mona D. Shah, MD, MBA
Adjunct Clinical Associate Professor, Pediatrics - Hematology & Oncology
BioDr. Mona Shah is a pediatric hematologist-oncologist, who earned her MD degree at the University of Maryland in 2001. She completed both her categorical pediatrics and global health residencies in 2004, followed by a pediatric hematology-oncology fellowship in 2007. She earned her MS in Clinical Investigation as part of the Clinical Scientist Training Program (CSTP) at Baylor College of Medicine in 2011, and more recently, completed an Executive MBA at Rice University Jones School of Business in 2018.
Dr. Shah was an Associate Professor at Baylor College of Medicine (2007 - 2020) in both Pediatrics and Medicine, local site PI on a number of pediatric hemostasis/thrombosis clinical trials, and spent 10 years as an Associate Medical Director of Clinical Operations, Quality, and Safety at Texas Children’s Hospital, Houston, TX.
Dr. Shah joined Genentech (a Member of the Roche Group)’s Rare Blood Disorders Franchise (Product Development - Oncology-Hematology) in February 2020, quickly advancing to Lead Medical Director, where she served as Medical Monitor for 2 Phase III Clinical Trials (crovalimab in atypical hemolytic uremic syndrome, aHUS). She was also engaged with the Renal Franchise (I2O) in developing crovalimab in Lupus Nephritis (Phase I & II Clinical Trials in development), and with Human Factors/Pediatric Formulations Working Group on autoinjector devices and oral formulations.
After completing a rotation in Early Development Safety (EDS), she was promoted to Senior Medical Safety Director in Late Stage Product Development, and was appointed Safety Strategy Lead for giredestrant in early and metastatic breast, ovarian, and endometrial cancer global clinical trials. She has experience in innovative study designs (adaptive/multi-drug), with FDA/EMA pediatric investigational plans, and health authority interactions. In June 2023, she was appointed Pediatric Safety Lead, in collaboration with the iPODD Team, supporting safety for pediatric indications and devices, and serves as the Co-Chair of the Pediatric Safety Expert Group.
Dr. Shah has kept and completed a bucket list since she was 7 years old (keeps growing): Running wild bouldering/rock climbing as a child in the Shenandoah/Blue Ridge Mountains, swimming with dolphins/piranhas in the Amazon, climbing inside a volcano caldera in Iceland, snorkeling the Great Barrier Reef ... have passport/will travel!
Since July 2022, she has joined Stanford University School of Medicine, as an Adjunct Clinical Associate Professor in the Department of Pediatrics, Division of Hematology-Oncology, where she enjoys teaching MSII students, and at the bedside in the Lucille Packard Bass Center Hematology Clinic. Dr. Shah enjoys free time in her new home base near San Francisco, where she hosts her visiting parents, friends, and extended family. -
Sejal Shah
Clinical Associate Professor, Pediatrics - Endocrinology
Current Research and Scholarly InterestsMy primary research interest is evaluating whether vitamin D supplementation can positively affect consequences of the metabolic syndrome in overweight and obese adolescents. Other research interests include evaluating the efficacy and biochemical profiles of various types of estrogen replacement in adolescent females.
-
Paul Sharek MD, MPH
Professor of Pediatrics (Hospital Medicine) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsResearch interests centered on hospital based quality of care improvement, and in particular pediatric patient safety. Areas of recent interest include developing practical tools to more accurately identify adverse medical events and to establish national rates of these adverse events. Additional areas of interest focus on developing the processes and systems to decrease the frequency of adverse drug events and adverse medical events at Children's hospitals in North America
